Norwegian startup ClexBio is bioengineering human veins to implant inside a patient’s body. Together with CSEM, a Swiss R&D centre, the company has built a prototype bioreactor to grow the veins.
Biological tissues have a remarkable ability to organize and change shape, driven by forces generated by their own cells. One of the major challenges in bioengineering is harnessing this natural ...
Researchers from MIT have developed a 3D-printable tissue adhesive that demonstrates superior tissue adhesion, rapid sealing capabilities across various surgical scenarios and a unique blood-repelling ...
YOKOHAMA, Japan--(BUSINESS WIRE)--CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up developing an artificial ligament derived from decellularized animal tissue, is the first company ...
Chronic wounds remain a significant clinical challenge, in part because it is difficult to deliver sustained, localized ...
YOKOHAMA, Japan, May 11, 2026--(BUSINESS WIRE)--CoreTissue BioEngineering Inc. ("CTBE"), a medical device start-up (Headquarters: Yokohama City, Kanagawa Prefecture, CEO: Yoji Jokura, Ph.D.) announces ...
An implantable tissue flap containing muscle and fat alongside a hierarchical network of blood and lymphatic vessels could offer hope for patients with severe tissue damage. An international research ...
Wesley LaBarge and the scaffold-free bioprinterThe dream of tissue engineering is a computer-controlled manufacturing of complex and functional human tissue for potential organ regeneration or ...
WASHINGTON, May 5, 2026 — Breast cancer impacts over 2 million women around the world each year. Following radiotherapy or chemotherapy, breast-conserving surgery is the first line of intervention for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results